SteelPeak Wealth’s Colgate-Palmolive CL Stock Holding History

SteelPeak Wealth’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	-$93.7K	–	591
2025 Q1	–	Hold	0	–	–	–	514

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SteelPeak Wealth's CL Position: Q4 2025 in Review

SteelPeak Wealth sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 5,755 shares — an estimated $460K sold.

SteelPeak Wealth first reported a position in CL in Q2 2020 and held it in 6 quarters. The position peaked at $460K in Q3 2025. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

SteelPeak Wealth reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
SteelPeak Wealth sold 5,755 Colgate-Palmolive shares in Q4 2025, an estimated $460K.
SteelPeak Wealth first reported a position in Colgate-Palmolive in Q2 2020 and held it in 6 quarters.
SteelPeak Wealth's Colgate-Palmolive position peaked at $460K in Q3 2025.
1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on SteelPeak Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.